A federal appeals court has ruled that a New Jersey law that permits terminally ill people to seek life-ending drugs applies only to residents of the state and not those from beyond its borders. The Philadelphia-based 3rd U.S. Circuit Court of Appeals rejected arguments challenging New Jersey’s residency requirement while acknowledging how fraught end-of-life decisions can be. The court noted that not all states have adopted the same approach. The opinion keeps New Jersey’s 2019 assisted suicide law intact.

  • Updated

Nancy Shine at her home in Los Altos, Calif., on Nov. 21, 2025. Shine is a scientist who donated blood plasma that is used to create the treatment for infant botulism. (AP Photo/Terry Chea)

  • Updated

A glass case displaying a vial of BabyBIG, the treatment for infant botulism is shown on Nov. 21, 2025 in Aos Altos, Calif. (AP Photo/Terry Chea)